Implementation of an evidence-based patient education Stoplight Tool to reduce cancer treatment-induced diarrhea
View File(s)
- Author(s)
- Details
-
Rebecca Kirkpatrick, BSN, RN, OCN, Clinical Coordinator (primary investigator); Kristine Bert, BSN, RN, OCN, Staff Nurse (co-investigator); Valerie Rinehart, BSN, RN, OCN, ONN-CG, Nurse Navigator (co-investigator); Melissa Fink, BSN, RN, OCN, Staff Nurse (co-investigator). All staff employed at John R Marsh Cancer Center, Hagerstown, Maryland.
- Sigma Affiliation
- Eta Eta
- Contributor Affiliation(s)
- John R. Marsh Cancer Center, Hagerstown, Maryland, USA
Visitor Statistics
Visits vs Downloads
Visitors - World Map
Top Visiting Countries
Country | Visits |
---|
Top Visiting Cities
City | Visits |
---|
Visits (last 6 months)
Downloads (last 6 months)
Popular Works for Kirkpatrick, Rebecca by View
Title | Page Views |
---|
Popular Works for Kirkpatrick, Rebecca by Download
Title | Downloads |
---|
View Citations
Citations
CID is a common side effect of chemotherapy treatment for patients with gastrointestinal cancers, which can result in ED visits, hospital admissions and delays in cancer treatment impacting overall survival. Prior research has explored treatment-related symptoms in older cancer patients and supported the need for patient education strategies to promote symptom management. Patient education tools designed in a stoplight format include three areas with green, yellow and red zones with interventions. The tools have improved management of symptoms and reduced readmissions in chronic diseases. No research studies on oncology patients have been done utilizing a stoplight education tool.
Type | Poster |
Acquisition | Self-submission |
Review Type | Abstract Review Only: Reviewed by Event Host |
Format | Text-based Document |
Evidence Level | Quasi-Experimental Study, Other |
Research Approach | Pilot/Exploratory Study |
Keywords | Diarrhea; Stoplight Tool; Chemotherapy-Induced |
Name | ONS Congress 2022 |
Host | Oncology Nursing Society |
Location | Anaheim, California, USA |
Date | 2022 |
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
License
The following license files are associated with this item:
Related items
Showing items related by title, author, creator and subjects.
-
Menopausal symptoms and quality of life in breast cancer patients undergoing chemotherapy-induced menopause
Park, Jin-Hee; Jo, YuJoung; Bae, Sun HyoungPremenopausal women who receive adjuvant chemotherapy for breast cancer may undergo premature menopause. The purposes of the study were to identify the severity of menopausal symptoms and its effects on quality of life ... -
Implementation of an evidence-based practice checklist to reduce 30-day readmission for patients with heart failure
Giscombe, Susan; Baptiste, Diana Lyn; Holley, Melissa Jones (2017-07-26)Readmissions for patients with heart failure are an ongoing concern for hospitals, healthcare policymakers, patients, and families. Clinicians must provide care that is safe and focuses on quality. This presentation will ... -
Efficacy of acupressure treatment at Neiguan Point with acupressure bands for chemotherapy-induced nausea, vomiting, and retching
Meyer, Christine D.Patients who receive chemotherapy perceive nausea and vomiting (N&V) to be one of the most problematic outcomes of chemotherapy. Even with the administration of a prophylactic antiemetic protocol, up to 33% of the patients ... -
Exercise to reduce chemotherapy-induced peripheral nephropathy: A pilot RCT
Kanzawa-Lee, Grace A.Oxaliplatin-induced peripheral neuropathy (OIPN) occurs in 85-95% of patients receiving FOLFOX or FOLFIRINOX, oxaliplatin-based chemotherapy for invasive gastrointestinal (GI) cancers. Persistent OIPN can impair long-term ... -
Evidence-based clinical practice on the interventions for oral mucositis for patients with cancer receiving treatment
Yan, Wang (2012-9-12)Objectives: This article is to develop a practical guideline on the interventions from prevention, treatment to nursing for the oral mucositis induced by anti-cancer treatment. Methods: Using keywords "mucositis, cancer", ...